150 related articles for article (PubMed ID: 31215546)
21. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.
Schuman JS; Horwitz B; Choplin NT; David R; Albracht D; Chen K
Arch Ophthalmol; 1997 Jul; 115(7):847-52. PubMed ID: 9230823
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.
Stewart WC; Sharpe ED; Day DG; Kolker AE; Konstas AG; Lee WH; Rieser JC; Chopra H; Holmes KT
J Ocul Pharmacol Ther; 2000 Jun; 16(3):251-9. PubMed ID: 10872922
[TBL] [Abstract][Full Text] [Related]
23. [Use of brimonidine 0.2% in treatment of glaucoma or ocular hypertony after poorly tolerated beta-blocker treatment].
Titouamane S; Baudouin C
J Fr Ophtalmol; 2002 Jun; 25(6):568-75. PubMed ID: 12223942
[TBL] [Abstract][Full Text] [Related]
24. Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension.
Adkins JC; Balfour JA
Drugs Aging; 1998 Mar; 12(3):225-41. PubMed ID: 9534022
[TBL] [Abstract][Full Text] [Related]
25. Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty.
David R; Spaeth GL; Clevenger CE; Perell HF; Siegel LI; Henry JC; Stiles MC; Passo MS; Stamper RL; Walt JG
Arch Ophthalmol; 1993 Oct; 111(10):1387-90. PubMed ID: 8105773
[TBL] [Abstract][Full Text] [Related]
26. The efficacy and safety of brimonidine 0.2% compared with timolol 0.5% in glaucoma: a randomized clinical trial on Taiwanese patients.
Chen MJ; Chou JC; Hsu WM; Liu JH
J Chin Med Assoc; 2003 May; 66(5):276-81. PubMed ID: 12908569
[TBL] [Abstract][Full Text] [Related]
27. Is brimonidine ophthalmic a safe therapy for infants?
Daubert GP
J Clin Pharm Ther; 2006 Jun; 31(3):289-92. PubMed ID: 16789995
[TBL] [Abstract][Full Text] [Related]
28. Effect of brimonidine tartrate on ocular hemodynamic measurements.
Lachkar Y; Migdal C; Dhanjil S
Arch Ophthalmol; 1998 Dec; 116(12):1591-4. PubMed ID: 9869786
[TBL] [Abstract][Full Text] [Related]
29. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients.
Toris CB; Camras CB; Yablonski ME
Am J Ophthalmol; 1999 Jul; 128(1):8-14. PubMed ID: 10482088
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of glaucoma with brimonidine (Alphagan 0.2%)].
Detry-Morel M; Dutrieux C
J Fr Ophtalmol; 2000 Oct; 23(8):763-8. PubMed ID: 11033496
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension.
Stewart WC; Day DG; Stewart JA; Holmes KT; Leech JN; Rowan CT; Schwartz GF
J Ocul Pharmacol Ther; 2000 Dec; 16(6):557-64. PubMed ID: 11132902
[TBL] [Abstract][Full Text] [Related]
32. Influence of topical brimonidine on visual field in glaucoma.
Ruiz Lapuente C; Ruiz Lapuente A; Link B
Eur J Ophthalmol; 2001; 11 Suppl 2():S67-71. PubMed ID: 11592534
[TBL] [Abstract][Full Text] [Related]
33. Role of alpha-2 agonists in neuroprotection.
Wheeler L; WoldeMussie E; Lai R
Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S47-51. PubMed ID: 12852434
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of 0.2% brimonidine for preventing intraocular pressure rise following argon laser trabeculoplasty.
Ma YR; Lee BH; Yang KJ; Park YG
Korean J Ophthalmol; 1999 Dec; 13(2):78-84. PubMed ID: 10761402
[TBL] [Abstract][Full Text] [Related]
35. [Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost].
Gebhardt DO
Ned Tijdschr Geneeskd; 1999 Jan; 143(5):275. PubMed ID: 10086159
[No Abstract] [Full Text] [Related]
36. Side-effect profile of brimonidine tartrate in children.
Al-Shahwan S; Al-Torbak AA; Turkmani S; Al-Omran M; Al-Jadaan I; Edward DP
Ophthalmology; 2005 Dec; 112(12):2143. PubMed ID: 16225927
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty.
Barnebey HS; Robin AL; Zimmerman TJ; Morrison JC; Hersh SB; Lewis RA; Coleman AL; Cinotti DJ; Walt J; Chen KS
Ophthalmology; 1993 Jul; 100(7):1083-8. PubMed ID: 8100625
[TBL] [Abstract][Full Text] [Related]
38. Effect of 0.2% brimonidine on retinal blood flow.
Yu M; Li Y; Liu X; Ling Y; Zheng X
Yan Ke Xue Bao; 2001 Mar; 17(1):42-5. PubMed ID: 12567595
[TBL] [Abstract][Full Text] [Related]
39. The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension.
Carlsson AM; Chauhan BC; Lee AA; LeBlanc RP
Am J Ophthalmol; 2000 Mar; 129(3):297-301. PubMed ID: 10704543
[TBL] [Abstract][Full Text] [Related]
40. The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension.
Stewart WC; Day DG; Stewart JA; Schuhr J; Latham KE
Am J Ophthalmol; 2001 May; 131(5):631-5. PubMed ID: 11336939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
